PERTH, Australia – Australia's Sonic Healthcare Ltd. is significantly expanding its U.S. footprint with the acquisition of Aurora Diagnostics LLC, of Palm Beach Gardens, Fla., for A$750 million (US$540 million) in an all-cash deal. About 90 percent of Aurora's revenue comes from its anatomical pathology services, and Sonic has deep roots in the anatomical pathology market. The acquisition extends Sonic's existing presence in anatomical pathology, which is a fragmented market in the U.S.
A now-little known band called the Classics IV made a big splash in 1968 when their Hallowe’en love song “Spooky” charted at #3 on the U.S. Billboard Hot 100, and eerie though it may sound, there might be a lesson in there for the FDA half a century later. Sound preposterous? Read on and decide for yourself. House (and Senate) on Haunted Hill As we’ve all seen, the FDA has proposed to pull the substantial equivalence standard for 510(k) filings, but the agency also acknowledged that these 510(k) submissions have ballooned over the past decade or so. Some of that...
RSS
